article thumbnail

Moving Beyond Medicine To Treat Chronic Pain

MedCity News

I look at non-pharmacological approaches like digital therapeutics as having the potential to give someone like me living with chronic pain everything I need to make a healthy recovery: access to digital treatments and clinicians, to community, coaching, and navigation services.

article thumbnail

Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine

MedCity News

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments. The post Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine appeared first on MedCity News.

Medicine 189
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s)

Pharmatutor

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s) admin Fri, 07/26/2024 - 10:52 Devansh Mehta* M.Pharmacy in Pharmacology, M.B.A. devanshm84@gmail.com

article thumbnail

Tackling the complex development landscape of pain medicines

European Pharmaceutical Review

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 102
article thumbnail

Alzheimer’s drug requires strengthened pharmacovigilance approach

European Pharmaceutical Review

A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting.

Safety 59
article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

While not a panacea, these technologies can be part of a comprehensive set of solutions that help close the gap of inequity in medicine and drug development.

Pharma 311
article thumbnail

First-in-class therapy approved for schizophrenia

European Pharmaceutical Review

after more than 30 years, there is now an entirely new pharmacological approach for schizophrenia” The oral muscarinic agonist is the first authorised antipsychotic schizophrenia drug that targets cholinergic receptors instead of dopamine receptors, which has been standard of care for this indication, according to the FDA.